Towards an effective chemotherapy of virus infections: Therapeutic potential of cidofovir [(S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, HPMPC] for the treatment of DNA virus infections

Collection of Czechoslovak Chemical Communications

Volumn 63, Issue 4, 1998, Pages 480-506

  De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Adenovirus; Cidofovir, Vistide; DNA viruses; Herpesvirus; HPMPC; Papillomavirus; Polyomavirus; Poxvirus

Indexed keywords

EID: 0032378483     PISSN: 00100765     EISSN: None     Source Type: Journal    
DOI: 10.1135/cccc19980480     Document Type: Article

References (65)

1. De Clercq E., Descamps J., De Somer P., Holý A.: Science 1978, 200, 563.
2. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beuuchamp L., Schaeffer H. J.: Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 5716.
3. Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P.: Nature 1978, 272, 583.
4. De Clercq E.: Trends Pharmacol Sci. 1982, 3, 492.
5. De Clercq E.: Biochem. Pharmacol. 1984, 33, 2159.
6. De Clercq E.: Biochem. Pharmacol. 1987, 36, 2567.
7. De Clercq E.: Biochem. Pharmacol. 1991, 42, 963.
8. Oberg B.: Pharmacol. Ther. 1982, 19, 387.
9. Holý A. in: Phosphorus Chemistry Directed Towards Biology (W. Stec, Ed.), p. 53. Pergamon Press, Oxford 1980.
10. Holý A., Rosenberg I.: Nucleic Acids Symp. Ser. 1981. 9, 145.
11. Rosenberg I., Holý A.: Collect. Czech. Chem. Commun. 1982, 47, 3447.
12. Veselý J., Rosenberg I., Holý A.: Collect. Czech. Chem. Commun. 1982, 47, 3464.
13. Horská K., Rosenberg I., Holý A., Šebesta K.: Collect. Czech. Chem. Commun. 1983, 48, 1352.
14. Rosenberg I., Holý A.: Collect. Czech. Chem. Commun. 1983, 48, 778.
15. Veselý J., Rosenberg I., Holý A.: Collect. Czech. Chem. Commun. 1983, 48, 1783.
16. Masojídková M., Zajíček J., Buděšínský M., Rosenberg I., Holý A.: Collect. Czech. Chem. Commun. 1985, 50, 1899.
17. Holý A., Nishizawa M., Rosenberg I., Votruba I.: Collect. Czech. Chem. Commun. 1987, 52, 3042.
18. De Clercq E., Holý A., Rosenberg I., Sakuma T., Balzarini J., Maudgal P. C.: Nature 1986, 323, 464.
19. De Clercq E., Sakuma T., Baba M., Pauwels R., Balzarini J., Rosenberg I., Holý A.: Antiviral Res. 1987, 8, 261.
20. De Clercq E.: Rev. Med. Virol. 1993, 3, 85.
21. Andrei G., Snoeck R., Vandeputte M., De Clercq E.: Antimicrob. Agents Chemother. 1997, 41, 587.
22. Neyts J., De Clercq E.: Antimicrob. Agents Chemother. 1997, 41, 2754.
23. Kedes D. H., Ganem D. J.: Clin. Invest. 1997, 99, 2082.
24. Andrei G., Snoeck R., Goubau P., Desmyter J., De Clercq E.: Eur. J. Clin. Microbiol. Infect. Dis. 1992, 11, 143.
25. Andrei G., Snoeck R., Schols D., Goubau P., Desmyter J., De Clercq E.: Eur. J. Clin. Microbiol. Infect. Dis. 1991, 10, 1026.
26. Cherrington J. M, Mulato A. S., Fuller M. D., Chen M. S.: Antimicrob. Agents Chemother. 1996, 40, 2212.
27. Yokota T., Mochizuki S., Konno K., Mori S., Shigeta S., De Clercq E.: Antimicrob. Agents Chemother. 1991, 35, 394.
28. Srinivas R. V., Connely M., Fridland A.: Antiviral Res. 1997, 35, 23.
29. Naesens L., Snoeck R., Andrei G., Balzarini J., Neyts J., De Clercq E.: Antiviral Chem. Chemother. 1997, 8, 1.
30. Snoeck R., Sakuma T., De Clercq E., Rosenberg I., Holý A.: Antimicrob. Agents Chemother. 1988, 32, 1839.
31. Neyts J., Snoeck R., Schols D., Balzarini J., De Clercq E.: Virology 1990, 179, 41.
32. Cihlář T., Votruba I., Horská K., Liboska R., Rosenberg I., Holý A.: Collect. Czech Chem. Commun. 1992, 57, 661.
33. Ho H.-T., Woods K. L., Bronson J. J., De Boeck H., Martin J. C., Hitchcock M. J. M.: Mol. Pharmacol. 1992, 41, 197.
34. Cihlář T., Chen M. S.: Mol. Pharmacol. 1996, 50, 1502.
35. Xiong X., Smith J. L., Kim C., Huang E.-S., Chen M. S.: Biochem. Pharmacol. 1996, 51, 1563.
36. Xiong X., Smith J. L., Chen M. S.: Antimicrob. Agents Chemother. 1997, 41, 594.
37. Neyts J., De Clercq E.: Antimicrob. Agents Chemother. 1998, 42, 170.
38. Gordon Y. J., Romanowski E. G., Araullo-Cruz T.: Invest. Ophthalmol. Visual Sci. 1994, 35, 4135.
39. de Oliveira C. B. R., Stevenson D., LaBree L., McDonnell P. J., Trousdale M. D.: Antiviral Res. 1996, 31, 165.
40. Kurtzman G., Pickel M., Christensen N., Kreider J.: 33rd ICAAC, New Orleans, Louisiana, U.S.A., October 17-20. 1993, Abstr No. 1593, 1993.
41. Neyts J., Sobis H., Snoeck R., Vandeputte M., De Clercq E.: Eur. J. Clin. Microbiol. Infect. Dis. 1993, 12, 269.
42. Lalezari J. P., Drew W. L., Glutzer E., James C., Miner D., Flaherty J., Fisher P. E., Cundy K., Hannigan J., Martin J. C., Jaffe H. S.: J. Infect. Dis. 1995, 171, 788.
43. Polis M. A., Spooner K. M., Baird B. F., Manischewitz J. F., Jaffe H. S., Fisher P. E., Falloon J., Davey R. T., Jr., Kovacs J. A., Walker R. E., Whitcup S. M., Nussenblatt R. B., Lane H. C., Masur H.: Antimicrob. Agents Chemother. 1995, 39, 882.
44. Cundy K. C., Petty B. G., Flaherty J., Fisher P. E., Polis M. A., Wachsman M., Lietman P. S., Lalezari J. P., Hitchcock M. J. M., Jaffe H. S.: Antimicrob. Agents Chemother. 1995, 39, 1247.
45. Lalezari J. P., Stagg R. J., Kuppermann B. D., Holland G. N., Kramer F., Ives D. V., Youle M., Robinson M. R., Drew W. L., Jaffe H. S.: Ann. Inter. Med. 1997, 126, 257.
46. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group: Ann. Inter. Med. 1997, 126, 264.
47. Wachsman M., Petty B. G., Cundy K. C., Jaffe H. S., Fisher P. E., Pastelak A., Lietman P. S.: Antiviral Res. 1996, 29, 153.
48. Hardy W. D.: J. Acquired Immune Defic. Syndr. 1997, 14 (Suppl. 1), S7.
49. Kirsch L. S., Arevalo J. F., De Clercq E., Chavez de la Paz E., Munguia D., Garcia R., Freeman W. R.: Am. J. Ophthalmol. 1995, 119, 466.
50. Kirsch L. S., Arevalo J. F., Chavev de la Paz E., Munguia D., De Clercq E., Freeman W. R.: Ophthalmology 1995, 102, 533.
51. Snoeck R., Andrei G., De Clercq E., Gerard M., Clumeck N., Tricot G., Sadzot-Delvaux C.: New Engl. J. Med. 1993, 329, 968.
52. Snoeck R., Andrei G., Gerard M., Silverman A., Hedderman A., Balzarini J., Sadzot-Delvaux C., Tricot G., Clumeck N., De Clercq E.: Clin. Infect. Dis. 1994, 18, 570.
53. Snoeck R., Gerard M., Sadzot-Delvaux C., Andrei G., Balzarini J., Reymen D., Ahadi N., De Bruyn J. M., Piette J., Rentier B., Clumeck N., De Clercq E.: J. Med. Virol. 1994, 42, 338.
54. Lalezari J. P., Drew W. L., Glutzer E., Miner D., Safri S., Owen W. F., Jr., Davidson J. M., Fisher P. E., Jaffe H. S.: J. Infect. Dis. 1994, 170, 570.
55. Lalezari J., Schacker T., Feinberg J., Gathe J., Lee S., Cheung T., Kramer F., Kessler H., Corey L., Drew W. L., Boggs J., McGuire B., Jaffe H. S., Safrin S.: J. Infect. Dis. 1997, 176, 892.
56. Sacks S. L., Sasadeusz J. J., Hughes A., Shafran S., Diaz-Mitoma F., Trottier S., Sibbald G., McGuire B. W., Rudy J., Jaffe H. S.: Presented at the Ninth International Conference on Antiviral Research, Urabandai, Fukushima, Japan, May 19-24, 1996.
57. Van Cutsem E., Snoeck R., Van Ranst M., Fiten P., Opdenakker G., Geboes K., Janssens J., Rutgeerts P., Vantrappen G., De Clereq E.: J Med. Virol. 1995, 45, 230.
58. Snoeck R., Wellens W., Desloovere C., Van Ranst M., Naesens L., De Clercq E., Feenstra L.: J. Med. Virol. 1998, 54, 219.
59. Snoeck R., Van Ranst M., Andrei G., De Clercq E., De Wit S., Poncin M., Clumeck N.: New Engl. J. Med. 1995, 333, 943.
60. Blick G., Garton T., Hopkins U., LaGravinese L.: J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 1997, 15, 84.
61. Meadows K. P., Tyring S. K., Pavia A T., Rallis T. M.: Arch. Dermatol. 1997, 133, 987.
62. Brosgart C., Roberts T., Safrin S., Marra C. M., Colson N., Jaffe H. S.: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 28 September-1 October 1997, Abstracts, p. 243, No. 1-5, 1997.
63. Snoeck R., Andrei G., De Clercq E.: Eur. J. Clin. Med. Infect. Dis. 1996, 15, 574.
64. Cherrington J. M.: Int. Antiviral News 1997, 5, 91.
65. Cherrington J. M., Miner R., Hitchcock M. J. M., Lalezari J. P., Drew W. L.: J. Infect. Dis. 1996, 173, 987.